Medtronic

This study follows 240 adults with mature dialysis fistulas to see how safe a balloon treatment is over the long term. It focuses on serious infections and death rates. The treatment is for new or returning blockages in the fistula.

This study follows 2,000 people who have or will get a special heart device lead (OmniaSecure) to treat fast heart rhythms. The goal is to see how safe and reliable the lead is over 5 years. Researchers will track any problems with the lead to make sure it works well for patients…

This study tracks over 1,000 people with heart failure who received a special heart device lead. The goal is to see how well the lead works and how safe it is over 5 years. Researchers are checking for any problems related to the lead. This is a follow-up study required by the FD…

This study looks at a special pacemaker feature called iATP that automatically sends painless signals to stop dangerously fast heartbeats (ventricular tachycardia). Researchers want to confirm it works safely in everyday use. About 2,200 people who already have or will get a comp…

This study follows 37,000 Medicare patients who received a Micra AV leadless pacemaker or a traditional pacemaker to compare complication rates and survival over two years. Researchers use insurance claims data to monitor safety. The goal is to gather real-world evidence on how w…

This study looks at how well a feature called TriageHF works in everyday medical practice to predict when heart failure might get worse. About 2200 people with heart failure who have a special implanted device (ICD or CRT) and use remote monitoring are included. The main goal is …

This study follows about 37,000 Medicare patients who received a Micra leadless pacemaker to treat slow heart rate (bradycardia). Researchers will use insurance claims data to check for complications within 30 days and survival rates over 2 years. The goal is to gather real-world…

This study is a registry that follows about 3100 people who receive a Micra pacemaker for a slow heart rhythm (bradycardia). The goal is to confirm the device works safely and effectively in routine medical practice after it was approved. Researchers will track complications and …